Journal
TUBERCULOSIS
Volume 134, Issue -, Pages -Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2022.102210
Keywords
Tregs; Pleural tuberculoma; T lymphocyte activation; Lymphocyte subsets
Categories
Funding
- Nanjing Health Science and Technology Development Special Fund [YKK18150]
Ask authors/readers for more resources
This study found that the expression of regulatory T cells (Tregs) is increased in patients with pleural tuberculoma (PTM) and decreases after treatment, indicating the important role of Tregs in the immune response of PTM.
Background: The expression of regulatory T cells (Tregs) is elevated in patients with active tuberculosis (TB) or multidrug-resistant TB. However, it remains uncertain whether Tregs mediate immune suppression in pleural tuberculoma (PTM). Methods: Peripheral venous blood and clinical data were collected from 56 PTM patients and 50 healthy volunteers. The expression of CD38 and HLA-DR expression in T cell subsets and Tregs was determined by flow cytometry. Results: PTM patients had significantly more Tregs than the matched healthy controls. The expression of CD4+T cells normalized after treatment. Although the median proportions of CD3+T, CD4+T, and CD8+T lymphocytes did not differ significantly between PTM patients and healthy controls, the CD4/CD8 ratio was higher in PTM patients. Moreover, the proportion of CD4+T lymphocytes expressing activation markers, including HLA-DR and CD38, was higher in PTM patients than healthy controls. Treg expression was positively associated with the level of CD4+T lymphocyte activation. Conclusions: The increased expression of Tregs seen in PTM patients, and subsequent decrease after treatment, indicate that Tregs play an important role in the immune reactivity of PTM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available